Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes

被引:58
|
作者
Castro, C. N. [1 ]
Barcala Tabarrozzi, A. E. [1 ]
Winnewisser, J. [1 ]
Gimeno, M. L. [1 ]
Antunica Noguerol, M. [1 ]
Liberman, A. C. [1 ]
Paz, D. A. [2 ]
Dewey, R. A. [3 ]
Perone, M. J. [1 ]
机构
[1] Univ Buenos Aires, Inst Invest Biomed Buenos Aires IBioB, CONICET Partner Inst, Max Planck Soc, Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Biol Desarrollo, Dept Biodiversidad Biol Expt,Inst Fisiol Biol Mol, Buenos Aires, DF, Argentina
[3] Inst Invest Biotecnol Inst Tecnol Chascomus IIB I, Lab Terapia Genica & Celulas Madre, Chascomus, Argentina
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2014年 / 177卷 / 01期
关键词
dendritic cells; inflammation; NOD mouse; T-bet; T lymphocytes;
D O I
10.1111/cei.12322
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Type 1 diabetes (T1DM) is a T cell-mediated autoimmune disease that selectively destroys pancreatic cells. The only possible cure for T1DM is to control autoimmunity against cell-specific antigens. We explored whether the natural compound curcumin, with anti-oxidant and anti-inflammatory activities, might down-regulate the T cell response that destroys pancreatic cells to improve disease outcome in autoimmune diabetes. We employed two accelerated autoimmune diabetes models: (i) cyclophosphamide (CYP) administration to non-obese diabetic (NOD) mice and (ii) adoptive transfer of diabetogenic splenocytes into NODscid mice. Curcumin treatment led to significant delay of disease onset, and in some instances prevented autoimmune diabetes by inhibiting pancreatic leucocyte infiltration and preserving insulin-expressing cells. To investigate the mechanisms of protection we studied the effect of curcumin on key immune cell populations involved in the pathogenesis of the disease. Curcumin modulates the T lymphocyte response impairing proliferation and interferon (IFN)- production through modulation of T-box expressed in T cells (T-bet), a key transcription factor for proinflammatory T helper type 1 (Th1) lymphocyte differentiation, both at the transcriptional and translational levels. Also, curcumin reduces nuclear factor (NF)-B activation in T cell receptor (TCR)-stimulated NOD lymphocytes. In addition, curcumin impairs the T cell stimulatory function of dendritic cells with reduced secretion of proinflammatory cytokines and nitric oxide (NO) and low surface expression of co-stimulatory molecules, leading to an overall diminished antigen-presenting cell activity. These in-vitro effects correlated with ex-vivo analysis of cells obtained from curcumin-treated mice during the course of autoimmune diabetes. These findings reveal an effective therapeutic effect of curcumin in autoimmune diabetes by its actions on key immune cells responsible for cell death.
引用
收藏
页码:149 / 160
页数:12
相关论文
共 50 条
  • [21] Insulin autoantibodies and antibodies in type 1 diabetes.
    Hampe, Christiane
    Hall, Tyler
    Ortqvist, Eva
    Torn, Carina
    Landin-Olsson, Mona
    Thomas, James
    CLINICAL IMMUNOLOGY, 2006, 119 : S172 - S172
  • [22] Prevalence of overweight and obesity in Type 1 diabetes.
    Fuks, AG
    Moraes, CMM
    Portella, RB
    Pinheiro, VS
    Oliveira, MMS
    Cunha, EF
    Gomes, MB
    DIABETOLOGIA, 2003, 46 : A119 - A119
  • [23] Antibodies to gliadin and endomysium in type 1 diabetes.
    Cinapri, V
    Quilici, S
    Forotti, G
    Giampietro, O
    Matteucci, E
    DIABETOLOGIA, 1999, 42 : A99 - A99
  • [24] Gender and albumin excretion in type 1 diabetes.
    Sibley, SD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 645A - 645A
  • [25] Autoimmune markers in slow type 1 diabetes: Confrontation to type 1 diabetes
    Desailloud, R
    Fajardy, I
    Vambergue, A
    Prevost, G
    Pigny, P
    Fontaine, P
    DIABETES & METABOLISM, 2000, 26 (05) : 353 - 360
  • [26] Autoimmunity and familial risk of type 1 diabetes.
    Hämäläinen A.M.
    Knip M.
    Current Diabetes Reports, 2002, 2 (4) : 347 - 353
  • [27] Type 1 on type 2 diabetes mellitus: Autoimmune type 1 diabetes superimposed on established type 2 diabetes
    Suzuki, Takahiro
    Takahashi, Kenji
    Miyamoto, Satoshi
    Ueno, Hiroyuki
    Takekawa, Sato
    Yoshida, Atsushi
    Fujita, Motohiro
    INTERNAL MEDICINE, 2007, 46 (24) : 1957 - 1962
  • [28] Differentially Expressed Micro-RNAs as Biomarkers for Prediction and Prognosis in Autoimmune Type 1 Diabetes.
    Chhabra, P.
    Gehrau, R.
    Hansen, J.
    Mas, V.
    Brayman, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 905 - 905
  • [29] Morphological remodeling of neuromuscular junction in a murine model of type I diabetes.
    Fahim, MA
    Hasan, MY
    FASEB JOURNAL, 1999, 13 (05): : A799 - A799
  • [30] Differentially Expressed Micro-RNAs as Biomarkers for Prediction and Prognosis in Autoimmune Type 1 Diabetes.
    Chhabra, P.
    Gehrau, R.
    Hansen, J.
    Mas, V.
    Brayman, K.
    TRANSPLANTATION, 2014, 98 : 905 - 905